Skip to content

To study and compare the effect of Raladi Lepa and Shrungaberadi Lepa in the managment of Dadru Kushta with special reference to Tinea (Corporis And Cruris)

RANDOMIZED CONTROLLED CLINICAL STUDY TO EVALUATE EFFICACY OF RALADI LEPA AND SHRUNGABERADI LEPA IN THE MANAGMENT OF DADRU KUSHTA WITH SPECIAL REFERENCE TO TINEA (CORPORIS AND CRURIS).

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/02/040479
Enrollment
80
Registered
2022-02-21
Start date
Unknown
Completion date
Unknown
Last updated
2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L309- Dermatitis, unspecified

Interventions

None listed

Sponsors

Dr Sachin Pawar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Subjects of Dadru with cardinal signs and symptoms Kandu (Itching),Raga(Redness), and Pidaka (Eruption) will be selected for this study. 2.Subjects between the age group of 18 to 70 years both inclusive will be selected for this study. 3.Both Male and Female (non-pregnant, non-lactating) gender Subjects are included in the study 4.Written consent showing willingness to participate in the study.

Exclusion criteria

Exclusion criteria: 1.Subjects of Severe/Chronic hepatic or renal disease . 2.Subjects with known Chronic Infectious Disease, such as active Tuberculosis, Hepatitis B or C, or HIV. 3.Chronicity more than 2 years. 4.Pregnant women and lactating mothers. 5.Age group below 18 and above 70 years.

Design outcomes

Primary

MeasureTime frame
Controlled study of Raladi lepa in Dadru kushta w.s.r. to tinea corporis and cruris Timepoint: 0 to 21 days

Secondary

MeasureTime frame
To study the efficacy of Raladi lepa in management of Dadru kushta To study the effects of Shrungaberadi lepa To compare the results of both groupsTimepoint: 0 to 21 days

Countries

India

Contacts

Public ContactDr Neena Damle

School of Ayurveda,Dr.D.Y.Patil Deemed to be University

sachya7654321@gmail.com7499468726

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026